Hosted by Dr. Tim Sayed · 🇺🇸 US · EN · 36 episodes
Established thought leaders with verified media credentials.
The Scalpel's Edge is a podcast hosted by Dr. Tim Sayed, a leading plastic surgeon and physician innovator, dedicated to exploring the forefront of excellence and wellness. The show delves into cutting-edge medical technologies, industry controversies, and innovative approaches to healthcare and personal growth. With insightful discussions featuring top leaders and innovators from healthcare and beyond, the podcast aims to optimize performance, enhance wellness, and deepen self-understanding. Listeners can follow the podcast on platforms like Apple and Spotify to join this journey into groundbreaking advancements and out-of-the-box thinking.
Dr. Tim Sayed hosts The Scalpel's Edge, a health show with 36 episodes published.
Dr. Tim Sayed walks through a recently accepted study from the Journal of Clinical Oncology Practice showing that GLP-1 medications like Ozempic, Mounjaro, and Zepbound are associated with a significant reduction in brea
Dr. Tim Sayed walks through a recent New York Times article on food noise — the persistent mental chatter about eating that many people with obesity describe as relentless — and what GLP-1 medications like semaglutide an
Dr. Tim Sayed walks through an April 2026 study published in Nature that analyzed over 410,000 Reddit posts from people using semaglutide and tirzepatide, using AI language models to extract and categorize what patients
Dr. Tim Sayed speaks with Rachel Blogg, a licensed psychotherapist and athlete who spent roughly three and a half years navigating breast augmentation, multiple revisions, capsular contracture, implant malposition, and e
Dr. Tim Sayed opens with a published personal account from a 56-year-old runner and author who had saline implants placed in the early 2000s and chose, two decades later, to have them removed and stay flat. The story mov
Dr. Tim Sayed takes a closer look at the latest shift in medically supervised weight loss with the FDA approval of an oral GLP-1 medication. After years of injections dominating the space, a once daily pill introduces a
Dr. Tim Sayed takes a thoughtful look at newly published data from the Achieve 3 trial, a 52-week head-to-head study comparing Eli Lilly’s investigational oral GLP-1, orforglipron, to oral semaglutide in adults with type
On The Scalpel’s Edge, Dr. Tim Sayed takes a clear-eyed look at where GLP-1 weight loss medications are headed and why the landscape feels so unsettled right now. From the FDA’s latest move against compounded GLP-1 drugs
Dr. Tim Sayed walks through some recent developments in the GLP-1 space that raise a question almost everyone on these medications eventually asks. What happens when you stop. He reflects on new data around weight regain
On The Scalpel’s Edge, Dr. Tim Sayed talks with Elizabeth Everett about her experience with breast implant illness and what it was like to spend years feeling dismissed while her body kept sending louder and louder signa
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights,
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes listeners inside the world of personalized genetic testing and how it can transform perioperative planning for explant patients and anyone seeking deeper insight
Explore the growing movement of breast implant removal as Dr. Tim Sayed breaks down why twenty four well known celebrities decided to explant. In this powerful episode of The Scalpel’s Edge, Dr. Sayed explains the emotio
A new era of weight management is on the horizon. In this episode of The Scalpel’s Edge, learn how oral GLP-1 medications like semaglutide (Rebelsus) are changing the landscape of obesity care and cardiovascular health.
In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months o
In this episode of The Scalpel’s Edge, Dr. Tim Sayed breaks down a recent CNN feature on the growing movement around explant surgery and breast implant illness. From celebrity testimonials like Alyssa Milano’s to the tro
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the shifting regulatory landscape for compounded GLP1 medications and what recent FDA warning letters mean for providers, pharmacies, and patien
On this episode of The Scalpel’s Edge we explore a fascinating new study showing how GLP1 medications like semaglutide and tirzepatide may not only improve heart failure outcomes but also reduce greenhouse gas emissions.
In this episode of The Scalpel’s Edge, Dr. Tim Sayed examines one of the most debated topics in plastic surgery, breast implant illness. He reviews findings from a arecent cohort study published in Cureus while also draw
On this episode of The Scalpel’s Edge, I’m diving into a fascinating new study that compares GLP-1 drugs like tirzepatide to traditional testosterone replacement therapy in men with obesity and low testosterone function.
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
The Scalpel's Edge has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
The Scalpel's Edge is hosted by Dr. Tim Sayed. The show is categorised under health (fitness) and has published 36 episodes.
The Scalpel's Edge has published 36 episodes.
The Scalpel's Edge regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
The Scalpel's Edge is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
The Scalpel's Edge hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of The Scalpel's Edge average 34 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates The Scalpel's Edge's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 5 days ago.
